Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology

International Journal of Infectious Diseases

Volumn 14, Issue 12, 2010, Pages

  Orozco Colín, Asunción ^a   Carrillo García, Adela ^b   Méndez Tenorio, Alfonso ^c   Ponce de León, Sergio ^d   Mohar, Alejandro ^b   Maldonado Rodríguez, Rogelio ^c   Guerra Arias, Rocío ^a   Flores Gil, Octavio ^a   Sotelo Regil, Rita ^b   Lizano, Marcela ^b  

^a Secretaria de Marina Mexico   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Genotype; Geographic distribution; HPV infection; Prevalence

Indexed keywords

ARTICLE; CYTOLOGY; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEXICO; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MEXICO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEXUAL PARTNERS; TUMOR VIRUS INFECTIONS;

EID: 78649634979     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.07.007     Document Type: Article

References (36)

1. Bosch X., Muñoz N. The viral etiology of cervical cancer. Virus Res 2002, 89:183-190.
2. Ferlay J., Bray F., Pisani P., Parkin DM GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5 version 2.0 2004, IARC Press, Lyon, France.
3. Lewis M.J. A situational analysis of cervical cancer in Latin America and the Caribbean 2004, Pan American Health Organization, Washington, DC.
4. World Health Organization. Human papillomavirus and related cancers. Summary report Mexico; 2010. Available at: , January 29, 2010. http://www.who.int/hpvcentre.
5. Denny L., Quinn M., Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine 2006, 24(Suppl. 3):71-77. [chapter 8].
6. Flores Y.N., Bishai D.M., Shah K.V., Lazcano-Ponce E., Lörincz A., Hernández M., et al. Risk factors for cervical cancer among HPV positive women in Mexico. Salud Publica Mex 2008, 50:49-58.
7. Palacio-Mejía L.S., Lazcano-Ponce E., Allen-Leigh B., Hernández-Ávila M. Diferencias regionales en la mortalidad por cáncer de mama y cérvix en México entre 1979 y 2006. Salud Publica Mex 2009, 51(Suppl. 2):S208-S219.
8. Palacio-Mejía L.S., Rangel-Gómez G., Hernández-Avila M., Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Publica Mex 2003, 45(Suppl. 3):S315-S325.
9. Bosch F.X., de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003, 31:3-13. [chapter 1].
10. Almonte M., Albero G., Molano M., Carcamo C., García P., Pérez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008, 26(Suppl. 11):L16-L36.
11. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl. 10):K1-K16.
12. de Sanjosé S., Diaz M., Castellsagué X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7:453-459.
13. Mammas I.N., Vageli D., Spandidos D.A. Geographic variations of human papilloma virus infection and their possible impact on the effectiveness of the vaccination programme. Oncol Rep 2008, 20:141-145.
14. Torroella-Kouri M., Morsberger S., Carrillo A., Mohar A., Meneses A., Ibarra M., et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 1998, 70:115-120.
15. Lazcano-Ponce E., Herrero R., Muñoz N., Cruz A., Shah K.V., Alonso P., et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001, 91:412-420.
16. Calleja-Macías I.E., Kalantari M., Huh J., Ortiz-Lopez R., Rojas-Martinez A., Gonzalez-Guerrero J.F., et al. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 2004, 319:315-323.
17. Lopez-Revilla R., Martinez-Contreras L., Sanchez-Garza M. Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma. Infect Agent Cancer 2008, 3:3.
18. Velazquez-Marquez N., Paredes-Telo M.A., Perez-Terron H., Santos-Lopez G., Reyes-Leyva J., Vallejo-Ruiz V. Prevalence of human papillomavirus genotypes in women from a rural region of Puebla, Mexico. Int J Infect Dis 2009, 13:690-695.
19. Resnick R., Cornelissen M., Wright D., Eichnigen G.H., Fox H.S., Schegget J., et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990, 82:1477-1484.
20. Husnjak K., Grce M., Magdic L., Paveli K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 2000, 88:125-134.
21. Carrillo A., Mohar A., Meneses A., Frías-Mendivil M., Solorza G., Lizano M. Utilidad en la combinación de oligonucleótidos universales para la detección del virus del papiloma humano en cáncer cervicouterino y lesiones premalignas. Salud Publica Mex 2004, 46:7-15.
22. Freeman G.H., Halton J.H. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951, 38:141-149. [Cited in: CYTEL Software Corp. StatXact 4 for Windows. Statistical software for exact nonparametric inference. User Manual. Cambridge: CYTEL; 1999, p. 614].
23. Zar J.H. Biostatistical analysis 1999, Prentice-Hall, New Jersey, p. 146-56. 4th ed.
24. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-24.
25. Illades-Aguiar B., Cortés-Malagón E.M., Antonio-Véjar V., Zamudio-López N., Alarcón-Romero L.C., Fernández-Tilapa G., et al. Cervical carcinoma in southern Mexico: human papillomavirus and cofactors. Cancer Detect Prev 2009, 32:300-307.
26. Sánchez-Anguiano L.F., Alvarado-Esquivel C., Reyes-Romero M.A., Carrera-Rodríguez M. Human papillomavirus infection in women seeking cervical Papanicolaou cytology of Durango, Mexico: prevalence and genotypes. BMC Infect Dis 2006, 6:27-32.
27. del Amo J., González C., Losana J., Clavo P., Muñoz L., Ballesteros J., et al. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 2005, 81:79-84.
28. Arbyn M., Sasieni P., Meijer C., Clavel C., Koliopoulos G., Dillner J. Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006, 24(Suppl. 3):78-89. [Chapter 9].
29. Smith J.S., Melendy A., Rana R.K., Pimenta J.M. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008, 43:S5-S25.
30. Burchell A.N., Teller P.P., Hanley J., Coutlee F., Franco E.L. Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner. Sex Transm Dis 2010, 37:34-40.
31. González-Losa M., Rosado-López I., Valdez-González N., Puerto-Solís M. High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J Clin Virol 2004, 29:202-205.
32. Delage M. La parentification des enfants: un exemple d'adaptation dans les familles de marins?. Med Armees 2002, 30:167-173.
33. Molano M., Huertas A., Hernández G., Martin C., Méndez F., Bravo M.M., et al. Presence and persistence of E6/HPV16 variants in the Colombian cohort. Abstract 7B-07, 104. 24th international papillomavirus conference and clinical workshop 2007.
34. Lizano M., De la Cruz-Hernández E., Carrillo-García A., García-Carrancá A., Ponce de León-Rosales S., Dueñas-González A., et al. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 2006, 102:230-235.
35. Xi L.F., Koutsky L.A., Hildesheim A., Galloway D.A., Wheeler C.M., Winer R.L., et al. Risk for high grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 2007, 16:4-10.
36. Berumen J., Ordoñez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001, 93:325-330.